AO-176

N/A

Report date: 2022/11/25 17:22:41

Base Information

Drug NameAO-176
Drug Alias NameAO-176Ti-104Ti-108Ti-176
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionCluster of differentiation 47 inhibitors
TargetsCluster of differentiation 47
Therapy Area/IndicationsSolid tumoursMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesArch Oncology Inc
China Registration ClassN/A

Develop Information

Active CompaniesArch Oncology Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A